Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Alx Oncology Holdings (ALXO) Other Gross PP&E Adjustments (2019 - 2023)

Alx Oncology Holdings' Other Gross PP&E Adjustments history spans 5 years, with the latest figure at $3.5 million for Q3 2023.

  • For Q3 2023, Other Gross PP&E Adjustments rose 191.48% year-over-year to $3.5 million; the TTM value through Sep 2023 reached $3.5 million, up 191.48%, while the annual FY2022 figure was -$2.2 million, 309.25% down from the prior year.
  • Other Gross PP&E Adjustments for Q3 2023 was $3.5 million at Alx Oncology Holdings, up from -$587000.0 in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $3.5 million in Q3 2023 and bottomed at -$4.7 million in Q2 2022.
  • The 5-year median for Other Gross PP&E Adjustments is -$530000.0 (2021), against an average of -$781666.7.
  • The largest YoY upside for Other Gross PP&E Adjustments was 275.65% in 2022 against a maximum downside of 18724.0% in 2022.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $2.2 million in 2019, then crashed by 110.2% to -$223000.0 in 2020, then plummeted by 137.67% to -$530000.0 in 2021, then plummeted by 309.25% to -$2.2 million in 2022, then soared by 261.46% to $3.5 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Other Gross PP&E Adjustments are $3.5 million (Q3 2023), -$587000.0 (Q2 2023), and -$1.6 million (Q1 2023).